Israeli weekly growth-hormone therapy edges closer to market
As with all daily injections, the treatment is often associated with poor levels of adherence.
OPKO Leadership Team (from left to right); Adam Logal, Senior Vice-President and Chief Financial Officer Jane H. Hsaio Ph.D., M.B.A., Chief Technical Officer and Vice Chairman Phillip Frost M.D., OPKO Health CEO & Chairman Steven D. Rubin, Executive Vice-President, Administration
